Medicine
Indium in-111 oxyquinoline 1 mCi/mL injection
Indium in-111 oxyquinoline 1 mCi/mL injection is a generic prescription medicine for intravenous use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
SPECIAL HANDLING AND STORAGE Indium In 111 oxyquinoline solution should be…
Key facts
- Active ingredient (INN)
- Indium in-111 oxyquinoline
- Brand
- Sold under the generic name
- Strength
- 1 mCi/mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 1 mL
- Manufacturer
- BWXT Medical
- Origin register
- US FDA, United States
- Storage
- SPECIAL HANDLING AND STORAGE Indium In 111 oxyquinoline solution should be stored at room temperature (15-25°C, 59-77°F). The labeled cells may be stored at room temperature (15-25°C, 59-77°F) tor up to three hours following completion of the cell labeling procedure.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 27 September 2019
- Identifiers
- DailyMed set ID 7dbfc0f9-0e2e-4aed-85bd-32cf7c74d402NDC 72536-0920Application ANDA202586
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 mL in 1 vial, single-dose | 72536-0920-1 | BWXT Medical | 27 September 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 24 December 1985 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Indium in-111 oxyquinoline
Clinical summary
Indium in-111 oxyquinoline is a radioactive diagnostic agent indicated for radiolabeling autologous leukocytes. It is available as injection for intravenous use. MedsAcross supplies Indium in-111 oxyquinoline for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Indium in-111 oxyquinolineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Indium in 111 Oxyquinoline prescribing information (GE Healthcare) · U.S. National Library of Medicine, DailyMed
Need Indium in-111 oxyquinoline 1 mCi/mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.